Axogen (AXGN) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$36.13
-0.1% on the day
+120.0% over 12 months
52-week range $15.59 – $51.73
Share price and insider trades
AXGN closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$19.3M
Insiders buying0
Insiders selling12
Axogen insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 12 sold $19.3M of AXGN stock on the open market.
Get emailed when insiders cluster-buy stocks like AXGN
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AXGN insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $4.7M | 4 |
| Q2 2026 | — | 0 | $1.7M | 7 |
| Q1 2026 | — | 0 | $171K | 1 |
| Q4 2025 | — | 0 | $13.4M | 35 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.4×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Axogen, Inc. insiders reported open-market purchases totaling $0, while 12 insiders reported sales totaling $19.3M. 17 of 47 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 4SEC | Joseph A. TyndallDirector | Sell Plan | 3,50010,650 held (−25%) | $49.70 | $174K | -27.3% | — |
| Aug 12SEC | Marc A BeganGeneral Counsel | Sell Plan | 67,50050,135 held (−57%) | $47.35 | $3.2M | -23.7% | — |
| Aug 12SEC | Amy Mcbride WendellDirector | Sell Plan | 13,353107,976 held (−11%) | $48.42 | $647K | -25.4% | — |
| Aug 11SEC | Kathy Johnson WeilerDirector | Sell Plan | 14,150 | $45.30 | $641K | -20.2% | — |
| May 12SEC | Amy Mcbride WendellDirector | Sell | 1,64793,826 held (−2%) | $42.60 | $70K | -15.2% | — |
| May 8SEC | Kathy Johnson WeilerDirector | Sell | 16,344 | $44.09 | $721K | -18.1% | — |
| May 8SEC | John JohnsonDirector | Sell | 11,050 | $43.26 | $478K | -16.5% | — |
| May 8SEC | Jens KempChief Marketing Officer | Sell | 4,00072,451 held (−5%) | $43.44 | $174K | -16.8% | — |
| May 8SEC | Doris QuackenbushSales Vp | Sell | 3,87892,416 held (−4%) | $43.51 | $169K | -17.0% | — |
| May 8SEC | Lindsey Marie HartleyCFO | Sell | 57365,146 held (−1%) | $43.67 | $25K | -17.3% | — |
| May 8SEC | Lindsey Marie HartleyCFO | Sell | 47862,756 held (−1%) | $43.67 | $21K | -17.3% | — |
| Mar 18SEC | Erick Wayne DevinneyChief Innovation Officer | Sell | 5,221262,781 held (−2%) | $32.84 | $171K | +10.0% | — |
| Dec 17SEC | Kathy Johnson WeilerDirector | Sell | 21,8256,580 held (−77%) | $29.55 | $645K | +22.3% | — |
| Dec 17SEC | Amy Mcbride WendellDirector | Sell | 20,436112,074 held (−15%) | $29.31 | $599K | +23.3% | — |
| Dec 17SEC | Kathy Johnson WeilerDirector | Sell | 18,24828,405 held (−39%) | $29.55 | $539K | +22.3% | — |
| Dec 17SEC | Amy Mcbride WendellDirector | Sell | 18,24893,826 held (−16%) | $29.31 | $535K | +23.3% | — |
| Dec 17SEC | Lindsey Marie HartleyCFO | Sell | 14,81231,376 held (−32%) | $29.86 | $442K | +21.0% | — |
| Dec 17SEC | Kathy Johnson WeilerDirector | Sell | 6,580 | $29.55 | $194K | +22.3% | — |
| Dec 17SEC | Amy Mcbride WendellDirector | Sell | 5,000132,510 held (−4%) | $29.31 | $147K | +23.3% | — |
| Dec 12SEC | Michael D DaleCEO | Sell | 25,00063,537 held (−28%) | $30.00 | $750K | +20.4% | — |
| Dec 12SEC | Marc A BeganGeneral Counsel | Sell | 13,22218,285 held (−42%) | $30.00 | $397K | +20.4% | — |
| Dec 10SEC | Michael D DaleCEO | Sell | 61,46388,537 held (−41%) | $31.21 | $1.9M | +15.8% | — |
| Dec 10SEC | Paul ThomasDirector | Sell | 21,39913,528 held (−61%) | $29.61 | $634K | +22.0% | — |
| Dec 10SEC | Erick Wayne DevinneyChief Innovation Officer | Sell | 19,517241,132 held (−7%) | $31.21 | $609K | +15.8% | — |
| Dec 10SEC | Joseph A. TyndallDirector | Sell | 14,24810,860 held (−57%) | $30.98 | $441K | +16.6% | — |
| Dec 10SEC | John JohnsonDirector | Sell | 13,141 | $29.98 | $394K | +20.5% | — |
| Dec 10SEC | John JohnsonDirector | Sell | 11,89113,141 held (−48%) | $31.22 | $371K | +15.7% | — |
| Dec 10SEC | John JohnsonDirector | Sell | 11,80213,141 held (−47%) | $31.26 | $369K | +15.6% | — |
| Dec 10SEC | Lindsey Marie HartleyCFO | Sell | 11,53334,230 held (−25%) | $31.56 | $364K | +14.5% | — |
| Dec 10SEC | Joseph A. TyndallDirector | Sell | 10,860 | $30.98 | $336K | +16.6% | — |
| Dec 10SEC | Marc A BeganGeneral Counsel | Sell | 9,27831,507 held (−23%) | $31.21 | $290K | +15.8% | — |
| Dec 10SEC | John JohnsonDirector | Sell | 8,54513,141 held (−39%) | $29.98 | $256K | +20.5% | — |
| Dec 10SEC | Jens KempChief Marketing Officer | Sell | 8,15646,030 held (−15%) | $31.21 | $255K | +15.8% | — |
| Dec 10SEC | Lindsey Marie HartleyCFO | Sell | 2,85431,376 held (−8%) | $31.56 | $90K | +14.5% | — |
| Nov 13SEC | William P. Mr. BurkeDirector | Sell Plan | 19,227100 held (−99%) | $24.01 | $462K | +50.5% | — |
| Nov 13SEC | William P. Mr. BurkeDirector | Sell Plan | 3,591100 held (−97%) | $24.02 | $86K | +50.4% | — |
| Nov 7SEC | William P. Mr. BurkeDirector | Sell Plan | 11,431100 held (−99%) | $24.05 | $275K | +50.2% | — |
| Nov 7SEC | William P. Mr. BurkeDirector | Sell Plan | 5,347100 held (−98%) | $24.01 | $128K | +50.5% | — |
| Oct 31SEC | William P. Mr. BurkeDirector | Sell Plan | 19,799100 held (−99%) | $22.00 | $436K | +64.2% | — |
| Oct 31SEC | William P. Mr. BurkeDirector | Sell Plan | 18,248100 held (−99%) | $23.00 | $420K | +57.1% | — |
| Oct 31SEC | William P. Mr. BurkeDirector | Sell Plan | 20,436100 held (−100%) | $19.15 | $391K | +88.7% | — |
| Oct 24SEC | William P. Mr. BurkeDirector | Sell Plan | 1,457100 held (−94%) | $18.02 | $26K | +100.5% | — |
| Oct 7SEC | William P. Mr. BurkeDirector | Sell Plan | 7361,557 held (−32%) | $18.00 | $13K | +100.7% | — |
| Oct 6SEC | William P. Mr. BurkeDirector | Sell Plan | 14,5712,293 held (−86%) | $18.21 | $265K | +98.4% | — |
| Oct 6SEC | William P. Mr. BurkeDirector | Sell Plan | 7,600 | $18.21 | $138K | +98.4% | — |
| Oct 6SEC | William P. Mr. BurkeDirector | Sell Plan | 7,62016,864 held (−31%) | $18.01 | $137K | +100.6% | — |
| Oct 6SEC | William P. Mr. BurkeDirector | Sell Plan | 2,4007,600 held (−24%) | $18.01 | $43K | +100.6% | — |
Insiders at Axogen, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Marc A BeganGeneral Counsel | — | $3.9M | Aug 12, 2026 | — |
| William P. Mr. BurkeDirector | — | $2.8M | Nov 13, 2025 | — |
| Kathy Johnson WeilerDirector | — | $2.7M | Aug 11, 2026 | — |
| Michael D DaleCEO | — | $2.7M | Dec 12, 2025 | — |
| Amy Mcbride WendellDirector | — | $2.0M | Aug 12, 2026 | — |
| John JohnsonDirector | — | $1.9M | May 8, 2026 | — |
| Joseph A. TyndallDirector | — | $952K | Sep 4, 2026 | — |
| Lindsey Marie HartleyCFO | — | $942K | May 8, 2026 | — |
| Erick Wayne DevinneyChief Innovation Officer | — | $781K | Mar 18, 2026 | — |
| Paul ThomasDirector | — | $634K | Dec 10, 2025 | — |
| Jens KempChief Marketing Officer | — | $428K | May 8, 2026 | — |
| Doris QuackenbushSales Vp | — | $169K | May 8, 2026 | — |
AXGN stock: common questions
Are Axogen, Inc. insiders buying AXGN stock?
In the past 12 months, 0 insiders reported open-market purchases of AXGN worth $0.
Are Axogen, Inc. insiders selling AXGN stock?
12 insiders reported sales worth $19.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AXGN's 52-week range?
Over the past year AXGN has traded between $15.59 and $51.73. It last closed at $36.13 on Oct 9, 2026.